On-target inhibition of <i>Cryptosporidium parvum</i> by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel <i>MDR1</i> -transgenic host cell model and algorithms to quantify on/off-target rates

Bo Yang(Sun Yat-sen University), Guan Zhu(Jilin University)
bioRxiv (Cold Spring Harbor Laboratory)
June 20, 2022
10.1101/2022.06.19.496759
Cited by 0

Related Papers

Examining the healthy human microbiome concept
|Nature Reviews Microbiology|2024|141
Enhanced stability and biocompatibility of HIPEs stabilized by cyclodextrin-metal organic frameworks with inclusion of resveratrol and soy protein isolate for β-carotene delivery
|International Journal of Biological Macromolecules|2024|37
Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease
|British Journal of Pharmacology|2023|16
On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target
|PLoS neglected tropical diseases|2023|9